Literature DB >> 2023927

Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

B Knebelmann1, L Boussin, D Guerrier, L Legeai, A Kahn, N Josso, J Y Picard.   

Abstract

The persistent Müllerian duct syndrome (PMDS) is characterized by the persistence of Müllerian derivatives, uterus and tubes, in otherwise normally virilized males. In a previous study, we showed that this syndrome is heterogeneous, with lack of production of anti-Müllerian hormone (AMH) by testicular tissue accounting for only some, AMH-negative, cases of this disorder. We have characterized the point mutation responsible for an AMH-negative PMDS in three siblings: a guanine to thymine transversion at position 2096 in the fifth exon changes a GAA triplet, coding for glutamic acid, to a TAA stop codon. The mutation could also be recognized, using the polymerase chain reaction, on RNA produced in trace amounts by a lymphoblastic cell line. The translation product, although undetectable in testicular tissue, could be visualized in culture medium of cells transfected with the mutant gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023927      PMCID: PMC51534          DOI: 10.1073/pnas.88.9.3767

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Cloning and expression of cDNA for anti-müllerian hormone.

Authors:  J Y Picard; R Benarous; D Guerrier; N Josso; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

4.  New amber mutation in a beta-thalassemic gene with nonmeasurable levels of mutant messenger RNA in vivo.

Authors:  G F Atweh; H E Brickner; X X Zhu; H H Kazazian; B G Forget
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19.

Authors:  O Cohen-Haguenauer; J Y Picard; M G Mattéi; S Serero; V C Nguyen; M F de Tand; D Guerrier; M C Hors-Cayla; N Josso; J Frézal
Journal:  Cytogenet Cell Genet       Date:  1987

6.  Phenylalanine hydroxylase deficiency caused by a single base substitution in an exon of the human phenylalanine hydroxylase gene.

Authors:  U Lichter-Konecki; D S Konecki; A G DiLella; K Brayton; J Marvit; T M Hahn; F K Trefz; S L Woo
Journal:  Biochemistry       Date:  1988-04-19       Impact factor: 3.162

7.  The persistent Müllerian duct syndrome: a molecular approach.

Authors:  D Guerrier; D Tran; J M Vanderwinden; S Hideux; L Van Outryve; L Legeai; M Bouchard; G Van Vliet; M H De Laet; J Y Picard
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

8.  Nonsense mutation causing steroid 21-hydroxylase deficiency.

Authors:  H Globerman; M Amor; K L Parker; M I New; P C White
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

9.  Immunocytochemical detection of anti-müllerian hormone in Sertoli cells of various mammalian species including human.

Authors:  D Tran; J Y Picard; J Campargue; N Josso
Journal:  J Histochem Cytochem       Date:  1987-07       Impact factor: 2.479

10.  Dysfunctional alpha-globin gene in hemoglobin H disease in blacks. A dinucleotide deletion produces a frameshift and a termination codon.

Authors:  S Safaya; R F Rieder
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

View more
  22 in total

Review 1.  Intersex disorder associated with ambiguous genitalia.

Authors:  M Rohatgi
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

Review 2.  Molecular determinants of sexual differentiation.

Authors:  J S Wiener; M Marcelli; D J Lamb
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Next-generation sequencing reveals genetic landscape in 46, XY disorders of sexual development patients with variable phenotypes.

Authors:  Hao Wang; Lele Zhang; Nan Wang; Hui Zhu; Bing Han; Feng Sun; Haijun Yao; Qiang Zhang; Wenjiao Zhu; Tong Cheng; Kaixiang Cheng; Yang Liu; Shuangxia Zhao; Huaidong Song; Jie Qiao
Journal:  Hum Genet       Date:  2018-03-26       Impact factor: 4.132

Review 4.  Genes involved in testicular development and function.

Authors:  D J Lamb
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 5.  The molecular genetics of human sex determination.

Authors:  U Wolf
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

Review 6.  The persistent müllerian duct syndrome: a rare cause of cryptorchidism.

Authors:  N Josso; J Y Picard; S Imbeaud; D Carré-Eusèbe; J Zeller; C Adamsbaum
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

7.  Testicular degeneration in three patients with the persistent müllerian duct syndrome.

Authors:  S Imbeaud; R Rey; P Berta; J L Chaussain; J M Wit; R H Lustig; M A De Vroede; J Y Picard; N Josso
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

Review 8.  H-Y antigens.

Authors:  U Müller
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

9.  Radiological findings in three cases of persistent müllerian duct syndrome.

Authors:  C Adamsbaum; Y Rolland; N Josso; G Kalifa
Journal:  Pediatr Radiol       Date:  1993

10.  Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments.

Authors:  B Knebelmann; G Deschenes; F Gros; M C Hors; J P Grünfeld; J Zhou; K Tryggvason; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.